AqueSys, Inc. Release: World Glaucoma Congress To Feature Symposium On XEN Gel Stent For Minimally Invasive IOP Reduction

ALISO VIEJO, Calif.--(BUSINESS WIRE)--AqueSys, Inc., the developer of minimally invasive stent technology for the treatment of glaucoma, announced today it will host a XEN Gel Stent Symposium at the 6th Annual World Glaucoma Congress (WGC) on Sunday, June 7, from 7:30-8:30 a.m. HKT. The symposium will be held in room S227 at the Hong Kong Convention and Exhibition Centre.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC